Semmelweis Publications
  • Main page

    • Department of Rheumatology and Clinical Immunology - Publications (article, review) in SJR Q1 and Q2 jorunals (2020-2024)

    Year:
    Order by:
    SU Authorship:
    Number of publications: 57
    1.
    EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
    Fanouriakis, A;Kostopoulou, M;Andersen, J;Aringer, M;Arnaud, L;Bae, SC;Boletis, J;Bruce, IN;Cervera, R;Doria, A;Doerner, T;Furie, RA;Gladman, DD;Houssiau, FA;Inês, LS;Jayne, D;Kouloumas, M;Kovács, L;Mok, CC;Morand, EF;Moroni, G;Mosca, M;Mucke, J;Mukhtyar, CB;Nagy, G;Navarra, S;Parodis, I;Pego-Reigosa, JM;Petri, M;Pons-Estel, BA;Schneider, M;Smolen, JS;Svenungsson, E;Tanaka, Y;Tektonidou, MG;Teng, YO;Tincani, A;Vital, EM;van Vollenhoven, RF;Wincup, C;Bertsias, G;Boumpas, DT
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2024.
    DOI:10.1136/ard-2023-224762 (Copy DOI)
    2.
    EULAR definition of difficult-to-treat rheumatoid arthritis
    Nagy, G;Roodenrijs, NMT;Welsing, PMJ;Kedves, M;Hamar, A;van der Goes, MC;Kent, A;Bakkers, M;Blaas, E;Senolt, L;Szekanecz, Z;Choy, E;Dougados, M;Jacobs, JWG;Geenen, R;Bijlsma, HWJ;Zink, A;Aletaha, D;Schoneveld, L;van Riel, P;Gutermann, L;Prior, Y;Nikiphorou, E;Ferraccioli, G;Schett, G;Hyrich, KL;Mueller-Ladner, U;Buch, MH;McInnes, IB;van der Heijde, D;van Laar, JM
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2021.
    DOI:10.1136/annrheumdis-2020-217344 (Copy DOI)
    3.
    Formation of a protein corona on the surface of extracellular vesicles in blood plasma
    Tóth, EA;Turiák, L;Visnovitz, T;Cserép, C;Mázló, A;Sódar, BW;Forsonits, AI;Petovári, G;Sebestyén, A;Komlósi, Z;Drahos, L;Kittel, A;Nagy, G;Bácsi, A;Dénes, A;Gho, YS;Szabó-Taylor, KÉ;Buzas, EI
    D1
    JOURNAL OF EXTRACELLULAR VESICLES
    2021.
    DOI:10.1002/jev2.12140 (Copy DOI)
    4.
    2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
    Fragoulis, GE;Nikiphorou, E;Dey, M;Zhao, SS;Courvoisier, DS;Arnaud, L;Atzeni, F;Behrens, GMN;Bijlsma, JWJ;Böhm, P;Constantinou, CA;Garcia-Diaz, S;Kapetanovic, MC;Lauper, K;Luís, M;Morel, J;Nagy, G;Poleverino, E;van Rompay, J;Sebastiani, M;Strangfeld, A;de Thurah, A;Galloway, J;Hyrich, KL
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2023.
    DOI:10.1136/ard-2022-223335 (Copy DOI)
    5.
    EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
    Nagy, G;Roodenrijs, NMT;Welsing, PMJ;Kedves, M;Hamar, A;van der Goes, MC;Kent, A;Bakkers, M;Pchelnikova, P;Blaas, E;Senolt, L;Szekanecz, Z;Choy, EH;Dougados, M;Jacobs, JWG;Geenen, R;Bijlsma, JWJ;Zink, A;Aletaha, D;Schoneveld, L;van Riel, P;Dumas, S;Prior, Y;Nikiphorou, E;Ferraccioli, G;Schett, G;Hyrich, KL;Mueller-Ladner, U;Buch, MH;McInnes, IB;van der Heijde, D;van Laar, JM
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2022.
    DOI:10.1136/annrheumdis-2021-220973 (Copy DOI)
    6.
    Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study
    López-Medina, C;Molto, A;Sieper, J;Duruöz, T;Kiltz, U;Elzorkany, B;Hajjaj-Hassouni, N;Burgos-Vargas, R;Maldonado-Cocco, J;Ziade, N;Gavali, M;Navarro-Compan, V;Luo, SF;Monti, S;Tae-Jong, K;Kishimoto, M;Pimentel-Santos, FM;Gu, JR;Schiotis, R;van Gaalen, FA;Geher, P;Magrey, M;Vodnizza, SEI;Bautista-Molano, W;Maksymowych, W;Machado, PM;Landew, R;van der Heijde, D;Dougados, M
    D1
    RMD OPEN
    2021.
    DOI:10.1136/rmdopen-2020-001450 (Copy DOI)
    Semmelweis University authors: Géher, Pál,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    7.
    Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
    Roodenrijs, NMT;Hamar, A;Kedves, M;Nagy, G;van Laar, JM;van der Heijde, D;Welsing, PMJ
    D1
    RMD OPEN
    2021.
    DOI:10.1136/rmdopen-2020-001512 (Copy DOI)
    8.
    B-cell depletion in autoimmune diseases
    Schett, G;Nagy, G;Krönke, G;Mielenz, D
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2024.
    DOI:10.1136/ard-2024-225727 (Copy DOI)
    9.
    Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin?
    Dey, M;Nagy, G;Nikiphorou, E
    D1
    RHEUMATOLOGY
    2023.
    DOI:10.1093/rheumatology/keac584 (Copy DOI)
    10.
    Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients
    Toth, L;Juhász, MF;Szabó, L;Abada, A;Kiss, F;Hegyi, P;Farkas, N;Nagy, G;Helyes, Z
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2022.
    DOI:10.3390/ijms23031246 (Copy DOI)
    11.
    To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate
    Cutolo, M;Shoenfeld, Y;Bogdanos, DP;Gotelli, E;Salvato, M;Gunkl-Tóth, L;Nagy, G
    D1
    AUTOIMMUNITY REVIEWS
    2024.
    DOI:10.1016/j.autrev.2023.103437 (Copy DOI)
    12.
    Photon-counting computed tomography in the assessment of rheumatoid arthritis-associated interstitial lung disease: an initial experience
    Marton, N;Gyebnar, J;Fritsch, K;Majnik, J;Nagy, G;Simon, J;Müller, V;Tarnoki, AD;Tarnoki, DL;Maurovich-Horvat, P
    Q2
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY
    2023.
    DOI:10.4274/dir.2023.221959 (Copy DOI)
    13.
    Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?
    Németh, T;Nagy, G;Pap, T
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2022.
    DOI:10.1136/annrheumdis-2021-222021 (Copy DOI)
    14.
    High Prevalence of Hemophagocytic Lymphohistiocytosis in Acute Liver Failure of Infancy
    Hadzic, N;Molnar, E;Height, S;Kovács, G;Dhawan, A;Andrikovics, H;Worth, A;Gilmour, KC
    Q1
    JOURNAL OF PEDIATRICS
    2022.
    DOI:10.1016/j.jpeds.2022.07.006 (Copy DOI)
    15.
    Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search
    Roodenrijs, NMT;Welsing, PMJ;van Roon, J;Schoneveld, JLM;van der Goes, MC;Nagy, G;Townsend, MJ;van Laar, JM
    D1
    RHEUMATOLOGY
    2022.
    DOI:10.1093/rheumatology/keac114 (Copy DOI)
    16.
    Myeloid Src-family kinases are critical for neutrophil-mediated autoinflammation in gout and motheaten models
    Futosi, K;Németh, T;Horváth, AI;Abram, CL;Tusnády, S;Lowell, CA;Helyes, Z;Mócsai, A
    D1
    JOURNAL OF EXPERIMENTAL MEDICINE
    2023.
    DOI:10.1084/jem.20221010 (Copy DOI)
    17.
    Novel and potential future therapeutic options in systemic autoimmune diseases
    Balogh, L;Oláh, K;Sánta, S;Majerhoffer, N;Németh, T
    Q1
    FRONTIERS IN IMMUNOLOGY
    2024.
    DOI:10.3389/fimmu.2024.1249500 (Copy DOI)
    18.
    Relationship between Gut, Blood, Aneurysm Wall and Thrombus Microbiome in Abdominal Aortic Aneurysm Patients
    Nemes-Nikodém,É;Gyurok, GP;Dunai, ZA;Makra, N;Hofmeister, B;Szabó, D;Sótonyi, P;Hidi, L;Szappanos, A;Kovács, G;Ostorházi, E
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2024.
    DOI:10.3390/ijms25168844 (Copy DOI)
    19.
    Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis
    Majnik, J;Császár-Nagy, N;Böcskei, G;Bender, T;Nagy, G
    Q1
    FRONTIERS IN MEDICINE
    2022.
    DOI:10.3389/fmed.2022.991677 (Copy DOI)
    20.
    Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis
    Meznerics, FA;Kemény, LV;Gunther, E;Bakó, E;Dembrovszky, F;Szabó, B;Ascsillán, A;Lutz, E;Csupor, D;Hegyi, P;Bánvölgyi, A;Nagy, G
    D1
    RHEUMATOLOGY
    2023.
    DOI:10.1093/rheumatology/keac715 (Copy DOI)
    21.
    ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
    Talarico, R;Ramirez, GA;Barreira, SC;Cardamone, C;Triggianese, P;Aguilera, S;Andersen, J;Avcin, T;Benistan, K;Bertsias, G;Bortoluzzi, A;Bouillot, C;Bulina, I;Burmester, GR;Callens, S;Carreira, PE;Cervera, R;Cutolo, M;Damian, L;Della Torre, E;Faria, R;Fonseca, JE;Galetti, I;Hachulla, E;Iaccarino, L;Jacobsen, S;Khmelinskii, N;Limper, M;Marinello, D;Meyer, A;Moroncini, G;Nagy, G;Olesinska, M;Pamfil, C;Pileckyte, M;Pistello, M;Rednic, S;Richez, C;Romao, VC;Schneider, M;Sciascia, S;Scirè, CA;Simonin...
    Q2
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    2023.
    DOI:10.55563/clinexprheumatol/jpargp (Copy DOI)
    22.
    Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritis
    Nemeth, D;Vago, H;Tothfalusi, L;Ulakcsai, Z;Becker, D;Szabo, Z;Rojkovich, B;Merkely, B;Nagy, G
    Q1
    FRONTIERS IN IMMUNOLOGY
    2022.
    DOI:10.3389/fimmu.2022.960001 (Copy DOI)
    23.
    The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET
    Talarico, R;Aguilera, S;Alexander, T;Amoura, Z;Andersen, J;Arnaud, L;Avcin, T;Barril, SM;Beretta, L;Bombardieri, S;Bortoluzzi, A;Bouillot, C;Bulina, I;Burmester, GR;Cannizzo, S;Cavagna, L;Chaigne, B;Cornet, A;Corti, P;Costedoat-Chalumeau, N;Davidsone, Z;Doria, A;Fenech, C;Ferraris, A;Fischer-Betz, R;Fonseca, JE;Frank, C;Gaglioti, A;Galetti, I;Guimaraes, V;Hachulla, E;Holmner, M;Houssiau, F;Iaccarino, L;Jacobsen, S;Limper, M;Malfait, F;Mariette, X;Marinello, D;Martin, T;Matthews, L;Matucci-Cerini...
    Q2
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    2022.
    DOI:10.55563/clinexprheumatol/d2qz38 (Copy DOI)
    24.
    Sustained drug-free remission in rheumatoid arthritis associated with diffuse large B-cell lymphoma following tandem CD20-CD19-directed non-cryopreserved CAR-T cell therapy using zamtocabtagene autoleucel
    Szabo, D;Balogh, A;Gopcsa, L;Giba-Kiss, L;Lakatos, G;Paksi, M;Reti, M;Takacs, P;van Heteren, P;Zadoyan, G;Holtkamp, S;Overstijns, T;Miltenyi, S;Remenyi, P;Nagy, G
    D1
    RMD OPEN
    2024.
    DOI:10.1136/rmdopen-2024-004727 (Copy DOI)
    25.
    Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline
    Nagy, A;Nagy, T;Kolonics-Farkas, AM;Eszes, N;Vincze, K;Barczi, E;Tarnoki, AD;Tarnoki, DL;Nagy, G;Kiss, E;Maurovich-Horvat, P;Bohacs, A;Muller, V
    Q1
    FRONTIERS IN PHARMACOLOGY
    2021.
    DOI:10.3389/fphar.2021.778649 (Copy DOI)
    26.
    Escalating SARS-CoV-2 specific humoral immune response in rheumatoid arthritis patients and healthy controls
    Nemeth, D;Vago, H;Tothfalusi, L;Ulakcsai, Z;Becker, D;Szabo, Z;Rojkovich, B;Gunkl-Toth, L;Merkely, B;Nagy, G
    Q1
    FRONTIERS IN IMMUNOLOGY
    2024.
    DOI:10.3389/fimmu.2024.1397052 (Copy DOI)
    27.
    How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?
    Balla, Z;Ignácz, B;Varga, L;Kohalmi, KV;Farkas, H
    D1
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
    2021.
    DOI:10.1007/s12016-021-08850-9 (Copy DOI)
    28.
    Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry
    Nagy, T;Toth, NM;Palmer, E;Polivka, L;Csoma, B;Nagy, A;Eszes, N;Vincze, K;Bárczi, E;Bohács, A;Tárnoki, AD;Tárnoki, DL;Nagy, G;Kiss, E;Maurovich-Horvát, P;Müller, V
    Q1
    BIOMEDICINES
    2022.
    DOI:10.3390/biomedicines10092129 (Copy DOI)
    29.
    Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
    Roodenrijs, NMT;Kedves, M;Hamar, A;Nagy, G;van Laar, JM;van der Heijde, D;Welsing, PMJ
    D1
    RMD OPEN
    2021.
    DOI:10.1136/rmdopen-2020-001511 (Copy DOI)
    30.
    Largely Accelerated Arterial Aging in Rheumatoid Arthritis Is Associated With Inflammatory Activity and Smoking in the Early Stage of the Disease
    Mong, N;Tarjanyi, Z;Tothfalusi, L;Bartykowszki, A;Nagy, AI;Szekely, A;Becker, D;Maurovich-Horvat, P;Merkely, B;Nagy, G
    Q1
    FRONTIERS IN PHARMACOLOGY
    2020.
    DOI:10.3389/fphar.2020.601344 (Copy DOI)
    31.
    Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox
    Nagy, A;Palmer, E;Polivka, L;Eszes, N;Vincze, K;Barczi, E;Bohacs, A;Tarnoki, AD;Tarnoki, DL;Nagy, G;Kiss, E;Maurovich-Horvat, P;Mueller, V
    Q1
    BIOMEDICINES
    2022.
    DOI:10.3390/biomedicines10020434 (Copy DOI)
    32.
    Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation
    Tani, C;Elefante, E;Arnaud, L;Barreira, SC;Bulina, I;Cavagna, L;Costedoat-Chalumeau, N;Doria, A;Fonseca, JE;Franceschini, F;Fredi, M;Iaccarino, L;Limper, M;Majnik, J;Nagy, G;Pamfil, C;Rednic, S;Reynolds, JA;Tektonidou, MG;Troldborg, A;Zanframundo, G;Mosca, M
    Q2
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    2022.
    DOI:10.55563/clinexprheumatol/jrz47c (Copy DOI)
    33.
    Balneotherapy, a Complementary Non-pharmacological Approach for Non-Inflammatory Complaints in Systemic Lupus Erythematosus: A Pilot Study
    Fritsch, K;Nagy, G;Szekanecz, Z;Szucs, G;Kovacs, L;Bender, T
    Q2
    IN VIVO
    2022.
    DOI:10.21873/invivo.13046 (Copy DOI)
    34.
    COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients
    Szekanecz, Z;Balog, A;Constantin, T;Czirják, L;Géher, P;Kovács, L;Kumánovics, G;Nagy, G;Rákóczi, É;Szamosi, S;Szucs, G;Vályi-Nagy, I
    Q2
    EXPERT REVIEWS IN MOLECULAR MEDICINE
    2022.
    DOI:10.1017/erm.2022.10 (Copy DOI)
    35.
    Preclinical models of arthritis for studying immunotherapy and immune tolerance
    Meehan, GR;Thomas, R;Al Khabouri, S;Wehr, P;Hilkens, CMU;Wraith, DC;Sieghart, D;Bonelli, M;Nagy, G;Garside, P;Tough, DF;Lewis, HD;Brewer, JM
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2021.
    DOI:10.1136/annrheumdis-2021-220043 (Copy DOI)
    36.
    Immunological response and temporal associations in myocarditis after COVID-19 vaccination using cardiac magnetic resonance imaging: An amplified T-cell response at the heart of it?
    Vago, H;Szabo, L;Szabo, Z;Ulakcsai, Z;Szogi, E;Budai, G;Toth, A;Juhasz, V;Dohy, Z;Hoffer, K;Becker, D;Kiss, RG;Nagy, GG;Nagy, G;Merkely, B
    Q1
    FRONTIERS IN CARDIOVASCULAR MEDICINE
    2022.
    DOI:10.3389/fcvm.2022.961031 (Copy DOI)
    37.
    Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study
    López-Medina, C;Chevret, S;Molto, A;Sieper, J;Duruöz, T;Kiltz, U;Elzorkany, B;Hajjaj-Hassouni, N;Burgos-Vargas, R;Maldonado-Cocco, J;Ziade, N;Gavali, M;Navarro-Compan, V;Luo, SF;Biglia, A;Tae-Jong, K;Kishimoto, M;Pimentel-Santos, FM;Gu, JR;Muntean, L;van Gaalen, FA;Geher, P;Magrey, M;Ibáñez-Vodnizza, SE;Bautista-Molano, W;Maksymowych, W;Machado, PM;Landewé, R;van der Heijde, D;Dougados, M
    D1
    RMD OPEN
    2021.
    DOI:10.1136/rmdopen-2021-001728 (Copy DOI)
    Semmelweis University authors: Géher, Pál,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    38.
    Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis
    Kiltz, U;Boonen, A;van der Heijde, D;Bautista-Molano, W;Vargas, RB;Chiowchanwisawakit, P;El-Zorkany, B;Gaydukova, I;Geher, P;Gossec, L;Gilio, M;Grazio, S;Gu, JR;Khan, MA;Kim, TJ;Maksymowych, WP;Marzo-Ortega, H;Navarro-Compán, V;Ozgocmen, S;Patrikos, D;Pimentel-Santos, FM;Reveille, J;Schirmer, M;Stebbings, S;Van den Bosch, F;Weber, U;Braun, J
    D1
    RHEUMATOLOGY
    2022.
    DOI:10.1093/rheumatology/keab653 (Copy DOI)
    Semmelweis University authors: Géher, Pál,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    39.
    Neutrophil-Specific Syk Expression Is Crucial for Skin Disease in Experimental Epidermolysis Bullosa
    Németh, T;Balogh, L;Káposztás, E;Szilveszter, KP;Mócsai, A
    D1
    JOURNAL OF INVESTIGATIVE DERMATOLOGY
    2023.
    DOI:10.1016/j.jid.2022.12.016 (Copy DOI)
    40.
    High risk of depression, anxiety, and an unfavorable complex comorbidity profile is associated with SLE: a nationwide patient-level study
    Kósa, F;Kunovszki, P;Gimesi-Országh, J;Kedves, M;Szabó, M;Karyekar, CS;Nagy, G
    Q1
    ARTHRITIS RESEARCH & THERAPY
    2022.
    DOI:10.1186/s13075-022-02799-6 (Copy DOI)
    41.
    T cell immune response predicts survival in severely ill COVID-19 patients requiring venovenous extracorporeal membrane oxygenation support
    Ulakcsai, Z;Szabo, L;Szabo, Z;Karaszi, E;Szabo, T;Fazekas, L;Vereb, A;Kovacs, NF;Nemeth, D;Kovacs, E;Nemeth, E;Nagy, G;Vago, H;Merkely, B
    Q1
    FRONTIERS IN IMMUNOLOGY
    2023.
    DOI:10.3389/fimmu.2023.1179620 (Copy DOI)
    42.
    Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
    Kajdácsi, E;Veszeli, N;Mezo, B;Jandrasics, Z;Kohalmi, KV;Ferrara, AL;Cervenak, L;Varga, L;Farkas, H
    D1
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
    2021.
    DOI:10.1007/s12016-021-08847-4 (Copy DOI)
    43.
    Signaling through Syk or CARD9 Mediates Species-Specific Anti-Candida Protection in Bone Marrow Chimeric Mice
    Zajta, E;Csonka, K;Tóth, A;Tiszlavicz, L;Németh, T;Orosz, A;Novák, A;Csikós, M;Vágvölgyi, C;Mócsai, A;Gácser, A
    D1
    MBIO
    2021.
    DOI:10.1128/mBio.01608-21 (Copy DOI)
    44.
    Activated polymorphonuclear derived extracellular vesicles are potential biomarkers of periprosthetic joint infection
    Sallai, I;Marton, N;Szatmári, A;Kittel, A;Nagy, G;Buzas, EI;Khamari, D;Komlósi, Z;Kristóf, K;Drahos, L;Turiák, L;Sugár, S;Veres, DS;Kendoff, D;Zahár, A;Skaliczki, G
    Q1
    PLOS ONE
    2022.
    DOI:10.1371/journal.pone.0268076 (Copy DOI)
    45.
    Proteomic Changes of Osteoclast Differentiation in Rheumatoid and Psoriatic Arthritis Reveal Functional Differences
    Kovacs, OT;Toth, E;Ozohanics, O;Soltesz-Katona, E;Marton, N;Buzas, EI;Hunyady, L;Drahos, L;Turu, G;Nagy, G
    Q1
    FRONTIERS IN IMMUNOLOGY
    2022.
    DOI:10.3389/fimmu.2022.892970 (Copy DOI)
    46.
    An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNET
    Bandeira, M;Di Cianni, F;Marinello, D;Arnaud, L;Cannizzo, S;Carta, C;Cornet, A;Barril, SM;Bulina, I;Ferraris, A;Fonseca, J;Gaglioti, A;Limper, M;Lorenzoni, V;Majnik, J;Matucci-Cerinic, M;Palla, I;Rednic, S;Schneider, M;Smith, V;Sulli, A;Sondergaard, K;Ticciati, S;Tincani, A;Turchetti, G;Talarico, R;Cutolo, M;Mosca, M;Taruscio, D
    Q1
    FRONTIERS IN MEDICINE
    2022.
    DOI:10.3389/fmed.2022.889997 (Copy DOI)
    Semmelweis University authors: Majnik, Judit Zsuzsanna,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    47.
    Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases
    Bandeira, M;Vieira, A;Guimaraes, V;Bento, T;Amoura, Z;Arnaud, L;Beretta, L;Cere, A;Chehab, G;Hachulla, E;Milas-Ahic, J;Müller-Ladner, U;Nagy, G;Piette, Y;Rednic, S;Schneider, M;Smith, V;Cutolo, M;Fonseca, JE;Romao, VC
    Q2
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    2022.
    DOI:10.55563/clinexprheumatol/v1e7s2 (Copy DOI)
    48.
    Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients
    Végh, E;Gaál, J;Géher, P;Gömöri, E;Kovács, A;Kovács, L;Nagy, K;Posta, EF;Tamási, L;Tóth, E;Varga, E;Domján, A;Szekanecz, Z;Szucs, G
    Q2
    BMC MUSCULOSKELETAL DISORDERS
    2021.
    DOI:10.1186/s12891-021-04192-x (Copy DOI)
    Semmelweis University authors: Géher, Pál,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    49.
    Impact of Medium-Sized Extracellular Vesicles on the Transduction Efficiency of Adeno-Associated Viruses in Neuronal and Primary Astrocyte Cell Cultures
    Kovács, OT;Soltész-Katona, E;Marton, N;Baricza, E;Hunyady, L;Turu, G;Nagy, G
    D1
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
    2021.
    DOI:10.3390/ijms22084221 (Copy DOI)
    50.
    Autoantibodies against complement factor B in rheumatoid arthritis
    Matola, AT;Fülöp, A;Rojkovich, B;Nagy, G;Sármay, G;Józsi, M;Uzonyi, B
    Q1
    FRONTIERS IN IMMUNOLOGY
    2023.
    DOI:10.3389/fimmu.2023.1113015 (Copy DOI)
    51.
    Points to consider: EULAR-UEMS standards for the training of European rheumatologists
    Alunno, A;Avcin, T;Haines, C;Ramiro, S;Sivera, F;Badreh, S;Baraliakos, X;Bijlsma, JWJ;Buttgereit, F;Chaudhuri, K;Da Silva, JAP;Dudler, J;Ferreira, RJO;Gudu, T;Hachulla, E;Holland-Fischer, M;Iagnocco, A;Kragstrup, TW;Nagy, G;Romao, VC;Stones, SR;van Onna, M;Edwards, CJ
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2023.
    DOI:10.1136/ard-2023-223941 (Copy DOI)
    Semmelweis University authors: Nagy, György,
    Semmelweis University departments: Semmelweis University, Faculty of Medicine, Department of Internal Medicine and Oncology,
    52.
    Viewpoint: Could better understanding of risk factors for comorbidities pave the way towards personalized therapy in rheumatoid arthritis?
    Majnik, J;Nagy, G
    D1
    RHEUMATOLOGY
    2023.
    DOI:10.1093/rheumatology/kead352 (Copy DOI)
    53.
    Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study
    Nagy, G;Géher, P;Tamási, L;Drescher, E;Keszthelyi, P;Pulai, J;Czirják, L;Szekanecz, Z;Kiss, G;Kovács, L
    Q2
    RHEUMATOLOGY ADVANCES IN PRACTICE
    2022.
    DOI:10.1093/rap/rkac038 (Copy DOI)
    54.
    The Role of Trace Elements in COPD: Pathogenetic Mechanisms and Therapeutic Potential of Zinc, Iron, Magnesium, Selenium, Manganese, Copper, and Calcium
    Fekete, M;Lehoczki, A;Csípo, T;Fazekas-Pongor, V;Szappanos, A;Major, D;Mózes, N;Dósa, N;Varga, JT
    D1
    NUTRIENTS
    2024.
    DOI:10.3390/nu16234118 (Copy DOI)
    55.
    The selective inhibition of the Syk tyrosine kinase ameliorates experimental autoimmune arthritis
    Káposztás, E;Balogh, L;Mócsai, A;Kemecsei, E;Jakus, Z;Németh, T
    Q1
    FRONTIERS IN IMMUNOLOGY
    2023.
    DOI:10.3389/fimmu.2023.1279155 (Copy DOI)
    56.
    Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol
    Ceglédi, A;Bátai, A;Dolgos, J;Fekete, M;Gopcsa, L;Király, V;Lakatos, G;Nagy, G;Szemlaky, Z;Várkonyi, A;Vilimi, B;Mikala, G;Bodó, I
    Q2
    PATHOLOGY & ONCOLOGY RESEARCH
    2024.
    DOI:10.3389/pore.2024.1611720 (Copy DOI)
    57.
    Time to address the challenge of difficult to treat psoriatic arthritis: results from an international survey
    Marzo-Ortega, H;Harrison, SR;Nagy, G;Machado, PM;McGonagle, DG;Aydin, SZ;Almodovar-González, R;Bautista-Molano, W;Gossec, L;Lubrano, E;Nash, P;Santos, FP;Soriano, ER;Siebert, S
    D1
    ANNALS OF THE RHEUMATIC DISEASES
    2024.
    DOI:10.1136/ard-2023-225087 (Copy DOI)

    Navigation

    Main page

    Publication search

    Department ranking

    Author ranking

    Author search

    Articles recently published in SJR D1 journals

    Top papers of the university

    Top field weighted citation impact publications

    Highly Cited Articles of Semmelweis University

    Semmelweis Publications
    Release: 2025_2
    Department data last refreshed at: 04.02.2025
    Author data last refreshed at: 04.02.2025
    (c) Semmelweis University - Central Library